Table 2 Univariate overall survival analysis with age at diagnosis, race, and initial tumor stage, PET/CT, and serum CA-125 and multivariate overall survival analysis with PET/CT and serum CA-125
From: Posttreatment FDG PET/CT in predicting survival of patients with ovarian carcinoma
Hazard ratio | Lower CIa | Upper CIa | p value | C-statistic | |
|---|---|---|---|---|---|
Univariate analysis | |||||
Age | 1.03 | 0.98 | 1.07 | 0.277 | 0.509 |
Race (White vs. non-White) | 0.53 | 0.16 | 1.82 | 0.316 | 0.518 |
Stage (stage ≥III vs. stage <III) | 1.02 | 0.24 | 4.41 | 0.975 | 0.513 |
Baseline CA-125 (log transformation) | 0.90 | 0.48 | 1.68 | 0.73 | 0.58 |
PET/CT (+ vs. −) | 4.18 | 1.49 | 11.70 | 0.006 | 0.683 |
CA-125 (+ vs. −) | 11.09 | 4.27 | 28.79 | <0.001 | 0.744 |
Multivariate analysis | |||||
PET/CT (+ vs. −) | 4.84 | 1.59 | 14.73 | 0.005 | 0.804 |
CA-125 (+ vs. −) | 14.43 | 4.65 | 44.84 | <0.001 |